Ken Griffin Franklin Templeton ETF Tr Geno Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Franklin Templeton ETF Tr Geno stock. As of the latest transaction made, Citadel Advisors LLC holds 63,368 shares of HELX stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,368

Previous 46,119 37.4%

Holding current value

$2 Million

Previous $1.45 Million 37.4%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	N/A	17,249 Added 37.4%	63,368 $2 Million
Q1 2025 May 15, 2025	BUY	N/A	38,153 Added 478.95%	46,119 $1.45 Million
Q4 2024 Feb 14, 2025	BUY	N/A	7,966 New	7,966 $250,000
Q1 2024 May 15, 2024	BUY	$29.38 - $32.86 $325,295 - $363,825	11,072 New	11,072 $362,000

Others Institutions Holding HELX

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About FRANKLIN TEMPLETON ETF TR GENO

Ticker HELX
Sector ETFs
Industry ETFs

More about HELX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account